Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
Addlife acquires Austrian-based Biomedica for EUR 39m
November 27, 2018

Life Science group Addlife has acquired the Austrian-based competitor Biomedica. Biomedica supplies products and services in the fields of laboratory technology and pharmaceutical technology in publicly funded healthcare. To fund the acquisition, Addlife has announced a rights issue worth SEK 500m. Biomedica reported a turnover of EUR 65m and EBITDA of EUR 4.4m by March 2018, corresponding to an EV/EBITDA multiple of 8.9x.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: